Connect your AI

Varonis Systems VRNS Available-for-Sale Securities (Non-Current)

Available-for-Sale Securities (Non-Current) at other companies

HubbellHUBB

$99.8M+14.8%

Teradyne, Inc.TER

$148.37M+30.4%

Royalty PharmaRPRX

$406.8M+85.8%

HubSpotHUBS

$87.52M-50.4%

Hims & Hers HealthHIMS

$0—

Neurocrine BiosciencesNBIX

$1.33B+63.3%

Other financials

Income statement

Revenue$173.1M+26.9%

Gross profit$131.6M+22.5%

Operating income-$44.5M-1.6%

Net income-$36.9M-3.0%

EPS (diluted)-$0.320.0%

Balance sheet

Cash & equivalents$179.3M+17.1%

Total debt$69.4M-77.0%

Total equity$453.5M+23.3%

Total assets$1.6B+3.6%

Cash flow

Operating cash flow$55.0M-19.1%

CapEx$5.0M+113%

Free cash flow$50.1M-23.7%

Valuation

Market cap$4.02B-44.6%

Profitability

Gross margin78.1%-4.2pp

Operating margin-22.3%+3.1pp

Net margin-19.7%+6.4pp

FCF margin18.1%-2.5pp

Returns & leverage

Return on equity-31.8%+24.0pp

Debt / equity0.2×-0.7×

Current ratio1.7×+0.5×

Where this comes from

Reported directly by Varonis Systems in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesNoncurrent.

The official record: Varonis Systems’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Varonis Systems's available-for-sale securities (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Varonis Systems's available-for-sale securities (non-current)?: Varonis Systems (VRNS) reported available-for-sale securities (non-current) of $113.61M in Q1 2026.
How has Varonis Systems's available-for-sale securities (non-current) changed year-over-year?: Varonis Systems's available-for-sale securities (non-current) decreased by 80.8% year-over-year, from $591.7M to $113.61M.